Search Results - Grasselly, Chloé

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

    The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent by Grasselly, Chloé, Denis, Morgane, Bourguignon, Aurore, Talhi, Nolan, Mathe, Doriane, Tourette, Anne, Serre, Laurent, Jordheim, Lars Petter, Matera, Eva Laure, Dumontet, Charles

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy

    Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy by Denis, Morgane, Mathé, Doriane, Micoud, Manon, Choffour, Pierre-Antoine, Grasselly, Chloé, Matera, Eva-Laure, Dumontet, Charles

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    IN VIVO SYNGENEIC TUMOR MODELS WITH ACQUIRED RESISTANCE TO ANTI-PD-1/PD-L1 THERAPIES

    IN VIVO SYNGENEIC TUMOR MODELS WITH ACQUIRED RESISTANCE TO ANTI-PD-1/PD-L1 THERAPIES by Denis, Morgane, Grasselly, Chloé, Choffour, Pierre-Antoine, Wierinckx, Anne, Mathe, Doriane, Chettab, Kamel, Tourette, Anne, Talhi, Nolan, Bourguignon, Aurore, Birzele, Fabian, Kress, Elsa, Jordheim, Lars Petter, Klein, Christian, Matera, Eva Laure, Dumontet, Charles

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract LB-078: Effect of a combined immune checkpoint inhibitor and mechanical focused ultrasound treatment on intratumoral immune response in a MC38 preclinical model

    Abstract LB-078: Effect of a combined immune checkpoint inhibitor and mechanical focused ultrasound treatment on intratumoral immune response in a MC38 preclinical model by Fant, Cécile, Grasselly, Chloé, Denis, Morgane, Mathé, Doriane, Choffour, Pierre-Antoine, Daunizeau, Loic, Mestas, Jean-Louis, Lafon, Cyril, Caux, Christophe, Depil, Stéphane, Dumontet, Charles, Padilla, Frédéric

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract 2723: In vivo activity of combinations of cytotoxic regimens with anti-PD1 and anti-PDL1 in various syngeneic cancer models

    Abstract 2723: In vivo activity of combinations of cytotoxic regimens with anti-PD1 and anti-PDL1 in various syngeneic cancer models by Grasselly, Chloé, Denis, Morgane, Bourguignon, Aurore, Talhi, Nolan, Tourette, Anne, Mathe, Doriane, Serre, Laurent, Jordheim, Lars Petter, Dumontet, Charles

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Abstract 4200: Characterization of acquired resistant models to therapies targeting the PD-1/PD-L1 axis demonstrates model-dependent mechanisms

    Abstract 4200: Characterization of acquired resistant models to therapies targeting the PD-1/PD-L1 axis demonstrates model-dependent mechanisms by Denis, Morgane, Grasselly, Chloé, Choffour, Pierre-Antoine, Wierinckx, Anne, Mathé, Doriane, Chettab, Kamel, Tourette, Anne, Talhi, Nolan, Birzele, Fabian, Kress, Elsa, Jordheim, Lars Petter, Klein, Christian, Matera, Eva-Laure, Dumontet, Charles

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: